|
Linfoma non-Hodgkin. Bendamustina più rituximab meglio della terapia standard
Quotidiano Sanità 20 FEB – L’associazione bendamustina più rituximab (B-R) in pazienti con linfoma non-Hodgkin indolente e mantellare raddoppia la sopravvivenza libera da progressione di malattia (PFS), rispetto al trattamento standard CHOP (ciclofosfamide, doxorubicina … |
|
Mundipharma’s bendamustine plus rituximab doubles PFS in non-Hodgkin …
The Pharma Letter Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line treatment regimen of bendamustine (marketed under the trade name Levact by privately-held Swiss drugmaker Mundipharma) plus rituximab (B-R) doubles … |
|
For further information please contact: Lara Dow,
BörseGo.de Auch wenn beim G20-Treffen am Wochenende die Gefahr eines drohenden „Währungskrieges“ bewusst kleingeredet wurde, befürchten Experten, das nach Japan auch andere Länder dazu übergehen könnten, ihre Währungen abzuwerten, um sich dadurch … |
– Treatment with bendamustine plus rituximab (BR) doubles progression free …EIN News (press release)Bendamustine is currently licensed for use after rituximab, an application has been made on the basis of this data for first line use. Results from th…
|
Phase 3 Data Published in The Lancet Show Bendamustine (Levact®) Plus …
SYS-CON Media (press release) Results from the StiL NHL-1 study published in the Lancet today show that a first-line treatment regimen of bendamustine plus rituximab (B-R) doubles progression-free survival (PFS) compared with the most often used treatment CHOP plus rituximab … |
MECHELEN, Belgium, February 20, 2013 /PRNewswire/ –PR Newswire UK (press release)Bendamustine is currently licensed for use after rituximab, an application has been made on the basis of this data for first line use. Results from the StiL NHL-1 study p…
Addition of rituximab to chlorambucil failed to improve OS in MALT lymphomaHealioResearchers compared chlorambucil (Leukeran, Aspen Global) alone with chlorambucil and rituximab (Rituxan, Genentech/Idec Pharmaceuticals) as initial therapy in a cohort o…
|
John Maunder gets ready for Yuleba World’s Greatest Shave
Warwick Daily News “It involves 8 treatments of fortnightly ABVD chemotherapy and a fortnightly dose of an antibody called Rituximab which targets the cancerous cells,” he said. “This will most likely be followed with involved-field radiotherapy which last a couple of … |
|
John Maunder gets ready for Yuleba World’s Greatest Shave
Toowoomba Chronicle “It involves 8 treatments of fortnightly ABVD chemotherapy and a fortnightly dose of an antibody called Rituximab which targets the cancerous cells,” he said. “This will most likely be followed with involved-field radiotherapy which last a couple of … |
|
ABT-199 Clinical Trial Suspended (Updated)
Corante Update: I’ve had email from the company, clarifying things a bit: “While AbbVie has voluntarily suspended enrollment in Phase 1 trials evaluating ABT-199 as a single agent and in combination with other agents such as rituximab, dosing of active … |